| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 6.61e-14 | 17 | 29 | 6 | GO:0004970 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 7.14e-13 | 24 | 29 | 6 | GO:0099507 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 1.57e-12 | 27 | 29 | 6 | GO:0008066 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.29e-10 | 105 | 29 | 7 | GO:0015171 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.86e-10 | 57 | 29 | 6 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 2.56e-10 | 60 | 29 | 6 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 4.21e-10 | 65 | 29 | 6 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 4.21e-10 | 65 | 29 | 6 | GO:0022824 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 1.02e-09 | 75 | 29 | 6 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.19e-09 | 77 | 29 | 6 | GO:0005230 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 5.87e-09 | 100 | 29 | 6 | GO:0030594 | |
| GeneOntologyMolecularFunction | AMPA glutamate receptor activity | 1.10e-08 | 4 | 29 | 3 | GO:0004971 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.50e-08 | 207 | 29 | 7 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.55e-08 | 208 | 29 | 7 | GO:0005342 | |
| GeneOntologyMolecularFunction | kainate selective glutamate receptor activity | 5.49e-08 | 6 | 29 | 3 | GO:0015277 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 1.53e-07 | 8 | 29 | 3 | GO:0022849 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 1.61e-07 | 293 | 29 | 7 | GO:0008514 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 2.98e-07 | 193 | 29 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 3.36e-07 | 197 | 29 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.64e-06 | 140 | 29 | 5 | GO:0099094 | |
| GeneOntologyMolecularFunction | ligand-gated sodium channel activity | 2.21e-06 | 18 | 29 | 3 | GO:0015280 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 3.26e-06 | 459 | 29 | 7 | GO:0005216 | |
| GeneOntologyMolecularFunction | gated channel activity | 7.19e-06 | 334 | 29 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | channel activity | 7.88e-06 | 525 | 29 | 7 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 7.98e-06 | 526 | 29 | 7 | GO:0022803 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.20e-05 | 31 | 29 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 2.49e-05 | 627 | 29 | 7 | GO:0022890 | |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 4.26e-05 | 7 | 29 | 2 | GO:0005234 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 4.65e-05 | 465 | 29 | 6 | GO:0046873 | |
| GeneOntologyMolecularFunction | sodium channel activity | 5.80e-05 | 52 | 29 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 8.30e-05 | 758 | 29 | 7 | GO:0015318 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 9.52e-05 | 167 | 29 | 4 | GO:0015079 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.04e-04 | 171 | 29 | 4 | GO:0015081 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 1.10e-04 | 793 | 29 | 7 | GO:0015075 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.23e-04 | 343 | 29 | 5 | GO:0005261 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 2.04e-04 | 1180 | 29 | 8 | GO:0022857 | |
| GeneOntologyMolecularFunction | L-glutamate transmembrane transporter activity | 2.11e-04 | 15 | 29 | 2 | GO:0005313 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 3.26e-04 | 664 | 29 | 6 | GO:0008324 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 3.27e-04 | 93 | 29 | 3 | GO:0097110 | |
| GeneOntologyMolecularFunction | transporter activity | 3.73e-04 | 1289 | 29 | 8 | GO:0005215 | |
| GeneOntologyMolecularFunction | acidic amino acid transmembrane transporter activity | 3.81e-04 | 20 | 29 | 2 | GO:0015172 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 4.29e-04 | 102 | 29 | 3 | GO:0001540 | |
| GeneOntologyMolecularFunction | potassium channel activity | 8.32e-04 | 128 | 29 | 3 | GO:0005267 | |
| GeneOntologyMolecularFunction | calcium channel activity | 8.51e-04 | 129 | 29 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | amide binding | 8.71e-04 | 299 | 29 | 4 | GO:0033218 | |
| GeneOntologyMolecularFunction | peptide binding | 1.09e-03 | 318 | 29 | 4 | GO:0042277 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.34e-03 | 151 | 29 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 1.77e-03 | 43 | 29 | 2 | GO:0005231 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 2.69e-03 | 1353 | 29 | 7 | GO:0004888 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 4.76e-03 | 71 | 29 | 2 | GO:0015179 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 1.37e-02 | 123 | 29 | 2 | GO:0030165 | |
| GeneOntologyMolecularFunction | SNARE binding | 1.66e-02 | 136 | 29 | 2 | GO:0000149 | |
| GeneOntologyMolecularFunction | antiporter activity | 1.70e-02 | 138 | 29 | 2 | GO:0015297 | |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 1.61e-12 | 27 | 30 | 6 | GO:0035235 | |
| GeneOntologyBiologicalProcess | ligand-gated ion channel signaling pathway | 2.06e-11 | 40 | 30 | 6 | GO:1990806 | |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 2.37e-10 | 59 | 30 | 6 | GO:0007215 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 6.74e-10 | 132 | 30 | 7 | GO:0035249 | |
| GeneOntologyBiologicalProcess | regulation of presynaptic membrane potential | 8.98e-10 | 32 | 30 | 5 | GO:0099505 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 2.03e-07 | 180 | 30 | 6 | GO:0060078 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission, glutamatergic | 7.86e-07 | 13 | 30 | 3 | GO:0051967 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission | 5.32e-06 | 80 | 30 | 4 | GO:0050805 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 9.29e-06 | 92 | 30 | 4 | GO:0051966 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission | 1.99e-05 | 233 | 30 | 5 | GO:0050806 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 1.32e-04 | 559 | 30 | 6 | GO:0042391 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | 3.05e-04 | 931 | 30 | 7 | GO:0098916 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | 3.05e-04 | 931 | 30 | 7 | GO:0007268 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | 3.21e-04 | 939 | 30 | 7 | GO:0099537 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 3.31e-04 | 663 | 30 | 6 | GO:0050804 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 3.34e-04 | 664 | 30 | 6 | GO:0099177 | |
| GeneOntologyBiologicalProcess | synaptic signaling | 4.06e-04 | 976 | 30 | 7 | GO:0099536 | |
| GeneOntologyBiologicalProcess | regulation of short-term neuronal synaptic plasticity | 4.64e-04 | 22 | 30 | 2 | GO:0048172 | |
| GeneOntologyBiologicalProcess | inhibitory postsynaptic potential | 7.02e-04 | 27 | 30 | 2 | GO:0060080 | |
| GeneOntologyBiologicalProcess | regulation of synaptic plasticity | 8.17e-04 | 293 | 30 | 4 | GO:0048167 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | 9.00e-04 | 1115 | 30 | 7 | GO:0034220 | |
| GeneOntologyBiologicalProcess | regulation of receptor recycling | 9.26e-04 | 31 | 30 | 2 | GO:0001919 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 1.25e-03 | 147 | 30 | 3 | GO:0099565 | |
| GeneOntologyBiologicalProcess | regulation of long-term neuronal synaptic plasticity | 1.54e-03 | 40 | 30 | 2 | GO:0048169 | |
| GeneOntologyBiologicalProcess | receptor recycling | 2.89e-03 | 55 | 30 | 2 | GO:0001881 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | 3.00e-03 | 1374 | 30 | 7 | GO:0006811 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 4.02e-11 | 45 | 30 | 6 | GO:0008328 | |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 5.16e-11 | 6 | 30 | 4 | GO:0032983 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 7.80e-11 | 50 | 30 | 6 | GO:0098878 | |
| GeneOntologyCellularComponent | sodium channel complex | 7.98e-08 | 29 | 30 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 8.34e-08 | 157 | 30 | 6 | GO:0098839 | |
| GeneOntologyCellularComponent | terminal bouton | 2.39e-07 | 96 | 30 | 5 | GO:0043195 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 3.59e-07 | 201 | 30 | 6 | GO:0099634 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 8.51e-07 | 378 | 30 | 7 | GO:0034702 | |
| GeneOntologyCellularComponent | presynaptic membrane | 2.33e-06 | 277 | 30 | 6 | GO:0042734 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 7.28e-06 | 523 | 30 | 7 | GO:1902495 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 8.92e-06 | 350 | 30 | 6 | GO:0098802 | |
| GeneOntologyCellularComponent | transporter complex | 1.01e-05 | 550 | 30 | 7 | GO:1990351 | |
| GeneOntologyCellularComponent | AMPA glutamate receptor complex | 1.05e-05 | 30 | 30 | 3 | GO:0032281 | |
| GeneOntologyCellularComponent | axon terminus | 1.13e-05 | 210 | 30 | 5 | GO:0043679 | |
| GeneOntologyCellularComponent | potassium channel complex | 1.43e-05 | 104 | 30 | 4 | GO:0034705 | |
| GeneOntologyCellularComponent | neuron projection terminus | 1.87e-05 | 233 | 30 | 5 | GO:0044306 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 2.04e-05 | 405 | 30 | 6 | GO:0045211 | |
| GeneOntologyCellularComponent | postsynaptic density | 3.73e-05 | 451 | 30 | 6 | GO:0014069 | |
| GeneOntologyCellularComponent | asymmetric synapse | 5.10e-05 | 477 | 30 | 6 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 6.84e-05 | 503 | 30 | 6 | GO:0099572 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 8.49e-05 | 523 | 30 | 6 | GO:0098984 | |
| GeneOntologyCellularComponent | receptor complex | 1.51e-04 | 581 | 30 | 6 | GO:0043235 | |
| GeneOntologyCellularComponent | synaptic membrane | 1.54e-04 | 583 | 30 | 6 | GO:0097060 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 1.89e-04 | 78 | 30 | 3 | GO:0048787 | |
| GeneOntologyCellularComponent | presynapse | 2.08e-04 | 886 | 30 | 7 | GO:0098793 | |
| GeneOntologyCellularComponent | axon | 2.15e-04 | 891 | 30 | 7 | GO:0030424 | |
| GeneOntologyCellularComponent | cation channel complex | 3.39e-04 | 235 | 30 | 4 | GO:0034703 | |
| GeneOntologyCellularComponent | distal axon | 3.54e-04 | 435 | 30 | 5 | GO:0150034 | |
| GeneOntologyCellularComponent | excitatory synapse | 4.79e-04 | 107 | 30 | 3 | GO:0060076 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 7.55e-04 | 785 | 30 | 6 | GO:0098797 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 9.29e-04 | 817 | 30 | 6 | GO:0098978 | |
| GeneOntologyCellularComponent | neuronal cell body | 1.04e-03 | 835 | 30 | 6 | GO:0043025 | |
| GeneOntologyCellularComponent | presynaptic active zone | 1.07e-03 | 141 | 30 | 3 | GO:0048786 | |
| GeneOntologyCellularComponent | dendrite | 1.20e-03 | 858 | 30 | 6 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 1.21e-03 | 860 | 30 | 6 | GO:0097447 | |
| GeneOntologyCellularComponent | dendrite cytoplasm | 1.43e-03 | 39 | 30 | 2 | GO:0032839 | |
| GeneOntologyCellularComponent | cell body | 1.80e-03 | 929 | 30 | 6 | GO:0044297 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | 2.10e-03 | 1307 | 30 | 7 | GO:0030659 | |
| GeneOntologyCellularComponent | vesicle membrane | 2.27e-03 | 1325 | 30 | 7 | GO:0012506 | |
| GeneOntologyCellularComponent | postsynapse | 2.85e-03 | 1018 | 30 | 6 | GO:0098794 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 3.41e-03 | 212 | 30 | 3 | GO:0030666 | |
| GeneOntologyCellularComponent | perikaryon | 3.93e-03 | 223 | 30 | 3 | GO:0043204 | |
| GeneOntologyCellularComponent | membrane protein complex | 4.51e-03 | 1498 | 30 | 7 | GO:0098796 | |
| GeneOntologyCellularComponent | dendritic spine | 4.94e-03 | 242 | 30 | 3 | GO:0043197 | |
| GeneOntologyCellularComponent | dendritic shaft | 5.04e-03 | 74 | 30 | 2 | GO:0043198 | |
| GeneOntologyCellularComponent | neuron spine | 5.23e-03 | 247 | 30 | 3 | GO:0044309 | |
| GeneOntologyCellularComponent | endoplasmic reticulum-Golgi intermediate compartment membrane | 6.01e-03 | 81 | 30 | 2 | GO:0033116 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 7.14e-03 | 1228 | 30 | 6 | GO:0036477 | |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 1.08e-02 | 110 | 30 | 2 | GO:0120111 | |
| GeneOntologyCellularComponent | endocytic vesicle | 1.73e-02 | 384 | 30 | 3 | GO:0030139 | |
| GeneOntologyCellularComponent | endoplasmic reticulum-Golgi intermediate compartment | 1.74e-02 | 141 | 30 | 2 | GO:0005793 | |
| MousePheno | abnormal glutamate-mediated receptor currents | 1.96e-08 | 55 | 22 | 5 | MP:0002886 | |
| MousePheno | abnormal AMPA-mediated synaptic currents | 8.59e-06 | 26 | 22 | 3 | MP:0002885 | |
| MousePheno | abnormal CNS synaptic transmission | 8.88e-06 | 985 | 22 | 9 | MP:0002206 | |
| MousePheno | abnormal synaptic transmission | 1.74e-05 | 1070 | 22 | 9 | MP:0003635 | |
| MousePheno | abnormal synaptic physiology | 1.82e-05 | 1076 | 22 | 9 | MP:0021009 | |
| MousePheno | abnormal long-term potentiation | 2.00e-05 | 221 | 22 | 5 | MP:0002207 | |
| MousePheno | induced hyperactivity | 3.73e-05 | 42 | 22 | 3 | MP:0008911 | |
| MousePheno | abnormal pain threshold | 4.94e-05 | 267 | 22 | 5 | MP:0001970 | |
| MousePheno | hypoalgesia | 1.30e-04 | 170 | 22 | 4 | MP:0003043 | |
| MousePheno | abnormal touch/ nociception | 2.47e-04 | 376 | 22 | 5 | MP:0001968 | |
| MousePheno | abnormal fear/anxiety-related behavior | 3.69e-04 | 919 | 22 | 7 | MP:0002065 | |
| MousePheno | decreased paired-pulse facilitation | 6.94e-04 | 25 | 22 | 2 | MP:0002920 | |
| MousePheno | abnormal miniature excitatory postsynaptic currents | 7.64e-04 | 116 | 22 | 3 | MP:0004753 | |
| MousePheno | abnormal anxiety-related response | 7.75e-04 | 740 | 22 | 6 | MP:0001362 | |
| MousePheno | decreased susceptibility to induction of seizure by inducing agent | 9.36e-04 | 29 | 22 | 2 | MP:0012348 | |
| MousePheno | decreased susceptibility to pharmacologically induced seizures | 9.36e-04 | 29 | 22 | 2 | MP:0002887 | |
| MousePheno | abnormal behavioral response to xenobiotic | 1.25e-03 | 309 | 22 | 4 | MP:0009745 | |
| MousePheno | reduced long-term potentiation | 1.34e-03 | 141 | 22 | 3 | MP:0001473 | |
| MousePheno | abnormal seizure response to pharmacological agent | 1.52e-03 | 147 | 22 | 3 | MP:0000950 | |
| MousePheno | abnormal nervous system electrophysiology | 1.58e-03 | 329 | 22 | 4 | MP:0002272 | |
| Domain | PBPe | 1.17e-13 | 18 | 28 | 6 | SM00079 | |
| Domain | Iono_rcpt_met | 1.17e-13 | 18 | 28 | 6 | IPR001508 | |
| Domain | Glu/Gly-bd | 1.17e-13 | 18 | 28 | 6 | IPR019594 | |
| Domain | Iontro_rcpt | 1.17e-13 | 18 | 28 | 6 | IPR001320 | |
| Domain | Lig_chan | 1.17e-13 | 18 | 28 | 6 | PF00060 | |
| Domain | Lig_chan-Glu_bd | 1.17e-13 | 18 | 28 | 6 | SM00918 | |
| Domain | Lig_chan-Glu_bd | 1.17e-13 | 18 | 28 | 6 | PF10613 | |
| Domain | ANF_receptor | 1.44e-11 | 37 | 28 | 6 | PF01094 | |
| Domain | ANF_lig-bd_rcpt | 1.44e-11 | 37 | 28 | 6 | IPR001828 | |
| Domain | Peripla_BP_I | 2.02e-11 | 39 | 28 | 6 | IPR028082 | |
| Domain | ARM-type_fold | 1.39e-02 | 339 | 28 | 3 | IPR016024 | |
| Pathway | WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING | 8.48e-10 | 140 | 21 | 7 | M42572 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 4.89e-08 | 144 | 21 | 6 | MM14501 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 3.40e-07 | 10 | 21 | 3 | M10272 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 3.98e-07 | 205 | 21 | 6 | M752 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 4.71e-07 | 211 | 21 | 6 | MM14502 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 6.21e-07 | 12 | 21 | 3 | MM15142 | |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 1.58e-06 | 16 | 21 | 3 | MM15048 | |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 1.91e-06 | 17 | 21 | 3 | M5488 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.99e-06 | 270 | 21 | 6 | M15514 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 2.08e-06 | 272 | 21 | 6 | M13380 | |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 2.29e-06 | 18 | 21 | 3 | M48098 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 3.20e-06 | 20 | 21 | 3 | MM15485 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 3.72e-06 | 21 | 21 | 3 | M27736 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 3.72e-06 | 21 | 21 | 3 | M838 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 4.31e-06 | 22 | 21 | 3 | M39795 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 4.31e-06 | 22 | 21 | 3 | MM15104 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 6.91e-06 | 335 | 21 | 6 | MM14503 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 1.02e-05 | 29 | 21 | 3 | MM15028 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 1.13e-05 | 30 | 21 | 3 | M18193 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 1.25e-05 | 31 | 21 | 3 | M7223 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 1.37e-05 | 32 | 21 | 3 | MM15143 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.81e-05 | 35 | 21 | 3 | MM15109 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 2.22e-05 | 411 | 21 | 6 | M735 | |
| Pathway | WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION | 2.93e-05 | 41 | 21 | 3 | M39655 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 1.28e-04 | 67 | 21 | 3 | MM15327 | |
| Pathway | WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME | 1.66e-04 | 73 | 21 | 3 | M39401 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 1.66e-04 | 73 | 21 | 3 | MM16641 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 1.68e-04 | 367 | 21 | 5 | M48346 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 2.79e-04 | 87 | 21 | 3 | M27617 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 3.50e-04 | 94 | 21 | 3 | M2843 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 4.80e-03 | 70 | 21 | 2 | M8232 | |
| Pubmed | Glutamate receptors in cortical plasticity: molecular and cellular biology. | 1.69e-18 | 7 | 30 | 6 | 9016303 | |
| Pubmed | Glutamate receptors: brain function and signal transduction. | 1.69e-18 | 7 | 30 | 6 | 9651535 | |
| Pubmed | Expression of glutamate receptor subunit genes during development of the mouse retina. | 2.03e-17 | 9 | 30 | 6 | 9051806 | |
| Pubmed | Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. | 4.13e-16 | 13 | 30 | 6 | 20859245 | |
| Pubmed | 7.05e-15 | 7 | 30 | 5 | 1310861 | ||
| Pubmed | Transmembrane topology of the glutamate receptor subunit GluR6. | 1.88e-14 | 8 | 30 | 5 | 8163463 | |
| Pubmed | 2.42e-14 | 23 | 30 | 6 | 8464923 | ||
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 3.22e-14 | 24 | 30 | 6 | 35746896 | |
| Pubmed | 2.65e-13 | 12 | 30 | 5 | 11891216 | ||
| Pubmed | RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. | 2.25e-12 | 5 | 30 | 4 | 1717158 | |
| Pubmed | 2.25e-12 | 5 | 30 | 4 | 9466455 | ||
| Pubmed | 1.41e-11 | 24 | 30 | 5 | 22534482 | ||
| Pubmed | 7.50e-11 | 81 | 30 | 6 | 22723691 | ||
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 31513786 | ||
| Pubmed | Differential trafficking of GluR7 kainate receptor subunit splice variants. | 5.79e-10 | 3 | 30 | 3 | 15805114 | |
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 19217372 | ||
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 1379666 | ||
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 12172541 | ||
| Pubmed | Kainate receptor-mediated responses in the CA1 field of wild-type and GluR6-deficient mice. | 5.79e-10 | 3 | 30 | 3 | 9880586 | |
| Pubmed | Excitatory glutamate is essential for development and maintenance of the piloneural mechanoreceptor. | 6.10e-10 | 15 | 30 | 4 | 22241839 | |
| Pubmed | 2.32e-09 | 4 | 30 | 3 | 10688364 | ||
| Pubmed | 2.32e-09 | 4 | 30 | 3 | 15513934 | ||
| Pubmed | 2.32e-09 | 4 | 30 | 3 | 1319477 | ||
| Pubmed | AMPA receptors regulate dynamic equilibrium of presynaptic terminals in mature hippocampal networks. | 2.32e-09 | 4 | 30 | 3 | 12692557 | |
| Pubmed | 2.32e-09 | 4 | 30 | 3 | 12125045 | ||
| Pubmed | AMPA receptor subunits expressed by single astrocytes in the juvenile mouse hippocampus. | 2.32e-09 | 4 | 30 | 3 | 9221927 | |
| Pubmed | Interaction proteomics reveals brain region-specific AMPA receptor complexes. | 2.32e-09 | 4 | 30 | 3 | 25337787 | |
| Pubmed | Auditory sensitivity regulation via rapid changes in expression of surface AMPA receptors. | 2.32e-09 | 4 | 30 | 3 | 17828255 | |
| Pubmed | Reduced synaptic function of Kainate receptors in the insular cortex of Fmr1 Knock-out mice. | 2.32e-09 | 4 | 30 | 3 | 30241548 | |
| Pubmed | 2.32e-09 | 4 | 30 | 3 | 24652293 | ||
| Pubmed | 2.32e-09 | 4 | 30 | 3 | 17409242 | ||
| Pubmed | 2.32e-09 | 4 | 30 | 3 | 19369569 | ||
| Pubmed | Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients. | 2.32e-09 | 4 | 30 | 3 | 19295509 | |
| Pubmed | 2.32e-09 | 4 | 30 | 3 | 14561864 | ||
| Pubmed | 2.32e-09 | 4 | 30 | 3 | 9648857 | ||
| Pubmed | 5.69e-09 | 300 | 30 | 7 | 19086053 | ||
| Pubmed | Developmental expression patterns of kainate receptors in the mouse spinal cord. | 5.78e-09 | 5 | 30 | 3 | 23076118 | |
| Pubmed | 5.78e-09 | 5 | 30 | 3 | 9482932 | ||
| Pubmed | Kainate receptors: pharmacology, function and therapeutic potential. | 5.78e-09 | 5 | 30 | 3 | 18793656 | |
| Pubmed | 5.78e-09 | 5 | 30 | 3 | 28228252 | ||
| Pubmed | 5.78e-09 | 5 | 30 | 3 | 12223554 | ||
| Pubmed | 5.78e-09 | 5 | 30 | 3 | 18358623 | ||
| Pubmed | 5.78e-09 | 5 | 30 | 3 | 16129400 | ||
| Pubmed | Development of laminar distributions of kainate receptors in the somatosensory cortex of mice. | 5.78e-09 | 5 | 30 | 3 | 9593973 | |
| Pubmed | Preferential assembly of heteromeric kainate and AMPA receptor amino terminal domains. | 5.78e-09 | 5 | 30 | 3 | 29058671 | |
| Pubmed | N-glycan content modulates kainate receptor functional properties. | 1.16e-08 | 6 | 30 | 3 | 28714086 | |
| Pubmed | 1.16e-08 | 6 | 30 | 3 | 18922769 | ||
| Pubmed | 2.02e-08 | 7 | 30 | 3 | 27076426 | ||
| Pubmed | 2.02e-08 | 7 | 30 | 3 | 21368048 | ||
| Pubmed | 2.02e-08 | 7 | 30 | 3 | 17428973 | ||
| Pubmed | Hippocampal AMPA receptor assemblies and mechanism of allosteric inhibition. | 2.02e-08 | 7 | 30 | 3 | 33981040 | |
| Pubmed | Impairment of AMPA receptor function in cerebellar granule cells of ataxic mutant mouse stargazer. | 2.02e-08 | 7 | 30 | 3 | 10407040 | |
| Pubmed | 2.02e-08 | 7 | 30 | 3 | 19342380 | ||
| Pubmed | Hippocampal AMPA receptor gating controlled by both TARP and cornichon proteins. | 3.23e-08 | 8 | 30 | 3 | 21172611 | |
| Pubmed | Synaptic profiles during neurite extension, refinement and retraction in the developing cochlea. | 3.23e-08 | 8 | 30 | 3 | 23217150 | |
| Pubmed | 4.85e-08 | 9 | 30 | 3 | 34100982 | ||
| Pubmed | 4.85e-08 | 9 | 30 | 3 | 24292102 | ||
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 5.50e-08 | 118 | 30 | 5 | 19156168 | |
| Pubmed | 1.65e-07 | 13 | 30 | 3 | 25218043 | ||
| Pubmed | 2.12e-07 | 60 | 30 | 4 | 32027825 | ||
| Pubmed | 2.62e-07 | 15 | 30 | 3 | 9481670 | ||
| Pubmed | PICK1 interacts with ABP/GRIP to regulate AMPA receptor trafficking. | 3.22e-07 | 16 | 30 | 3 | 16055064 | |
| Pubmed | 3.91e-07 | 17 | 30 | 3 | 32185508 | ||
| Pubmed | Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation. | 4.68e-07 | 18 | 30 | 3 | 18311135 | |
| Pubmed | 4.68e-07 | 18 | 30 | 3 | 34455539 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 12947409 | ||
| Pubmed | Assessing the role of GLUK5 and GLUK6 at hippocampal mossy fiber synapses. | 7.19e-07 | 2 | 30 | 2 | 15537878 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 15673679 | ||
| Pubmed | Subunit composition of kainate receptors in hippocampal interneurons. | 7.19e-07 | 2 | 30 | 2 | 11144357 | |
| Pubmed | Amyloid-β effects on synapses and memory require AMPA receptor subunit GluA3. | 7.19e-07 | 2 | 30 | 2 | 27708157 | |
| Pubmed | Synaptic plasticity through activation of GluA3-containing AMPA-receptors. | 7.19e-07 | 2 | 30 | 2 | 28762944 | |
| Pubmed | Distinct effects of AMPAR subunit depletion on spatial memory. | 7.19e-07 | 2 | 30 | 2 | 37876813 | |
| Pubmed | Differential distribution of ionotropic glutamate receptor subunits in the rat olfactory bulb. | 7.19e-07 | 2 | 30 | 2 | 10023812 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 19320626 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 25043179 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 15094479 | ||
| Pubmed | Kinetic properties of human AMPA-type glutamate receptors expressed in HEK293 cells. | 7.19e-07 | 2 | 30 | 2 | 12670305 | |
| Pubmed | Absence seizures in C3H/HeJ and knockout mice caused by mutation of the AMPA receptor subunit Gria4. | 7.19e-07 | 2 | 30 | 2 | 18316356 | |
| Pubmed | Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. | 7.19e-07 | 2 | 30 | 2 | 7992055 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 11182092 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 20579352 | ||
| Pubmed | Kainate receptor-mediated synaptic transmission in the adult anterior cingulate cortex. | 7.19e-07 | 2 | 30 | 2 | 15928066 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 15358807 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 14724198 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 28103481 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 17620617 | ||
| Pubmed | Q/R site editing in kainate receptor GluR5 and GluR6 pre-mRNAs requires distant intronic sequences. | 7.19e-07 | 2 | 30 | 2 | 8700852 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 15539395 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 17928436 | ||
| Pubmed | Elimination of redundant synaptic inputs in the absence of synaptic strengthening. | 7.19e-07 | 2 | 30 | 2 | 22090494 | |
| Pubmed | Characterization of the functional role of the N-glycans in the AMPA receptor ligand-binding domain. | 7.19e-07 | 2 | 30 | 2 | 12603841 | |
| Pubmed | Role of GluK1 kainate receptors in seizures, epileptic discharges, and epileptogenesis. | 7.19e-07 | 2 | 30 | 2 | 24760837 | |
| Pubmed | A mosaic of functional kainate receptors in hippocampal interneurons. | 7.19e-07 | 2 | 30 | 2 | 15483117 | |
| Pubmed | Functional characterization of kainate receptors in the mouse nucleus accumbens. | 7.19e-07 | 2 | 30 | 2 | 11985817 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 7696618 | ||
| Pubmed | Atypical functional properties of GluK3-containing kainate receptors. | 7.19e-07 | 2 | 30 | 2 | 20007474 | |
| Pubmed | Q/R site editing controls kainate receptor inhibition by membrane fatty acids. | 7.19e-07 | 2 | 30 | 2 | 16221857 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 16219388 | ||
| Pubmed | Mechanisms underlying signal filtering at a multisynapse contact. | 7.19e-07 | 2 | 30 | 2 | 22396411 | |
| Pubmed | Expression and novel subunit isoforms of glutamate receptor genes GluR5 and GluR6. | 7.19e-07 | 2 | 30 | 2 | 8260617 | |
| Interaction | GRIK2 interactions | 1.39e-07 | 32 | 30 | 4 | int:GRIK2 | |
| Interaction | GRIK4 interactions | 1.66e-07 | 8 | 30 | 3 | int:GRIK4 | |
| Interaction | GRIP1 interactions | 2.86e-07 | 96 | 30 | 5 | int:GRIP1 | |
| Interaction | GRIK3 interactions | 3.55e-07 | 10 | 30 | 3 | int:GRIK3 | |
| Interaction | GRIK5 interactions | 3.34e-06 | 20 | 30 | 3 | int:GRIK5 | |
| Interaction | GRIA1 interactions | 7.78e-06 | 86 | 30 | 4 | int:GRIA1 | |
| Interaction | GRIK1 interactions | 2.06e-05 | 36 | 30 | 3 | int:GRIK1 | |
| Interaction | GRIA4 interactions | 3.05e-05 | 41 | 30 | 3 | int:GRIA4 | |
| Interaction | GRIA3 interactions | 3.53e-05 | 43 | 30 | 3 | int:GRIA3 | |
| Interaction | TRO interactions | 1.46e-04 | 69 | 30 | 3 | int:TRO | |
| Interaction | GRIA2 interactions | 2.23e-04 | 203 | 30 | 4 | int:GRIA2 | |
| Interaction | NUP43 interactions | 2.73e-04 | 625 | 30 | 6 | int:NUP43 | |
| GeneFamily | Glutamate ionotropic receptor AMPA type subunits | 5.40e-09 | 4 | 21 | 3 | 1200 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 1.35e-08 | 5 | 21 | 3 | 1199 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | 2.01e-05 | 506 | 30 | 6 | M39067 | |
| Coexpression | GSE2585_CD80_HIGH_VS_LOW_MTEC_UP | 7.72e-05 | 200 | 30 | 4 | M6276 | |
| Coexpression | GSE43955_1H_VS_10H_ACT_CD4_TCELL_UP | 7.72e-05 | 200 | 30 | 4 | M9658 | |
| Coexpression | MCCLUNG_COCAINE_REWARD_5D | 8.64e-05 | 75 | 30 | 3 | MM658 | |
| Coexpression | MCCLUNG_COCAINE_REWARD_5D | 8.64e-05 | 75 | 30 | 3 | M1539 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.20e-06 | 152 | 30 | 4 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.99e-06 | 170 | 30 | 4 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.99e-06 | 170 | 30 | 4 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | 18-Airway-Epithelial-Submucosal_gland_basal|Airway / Age, Tissue, Lineage and Cell class | 6.40e-06 | 181 | 30 | 4 | 33938e6521712058312879f84f4ae381c2bfc379 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.83e-06 | 184 | 30 | 4 | 23515c28e1f42aab29cef9e5b4a7f45bda7f5520 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.28e-06 | 187 | 30 | 4 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.91e-06 | 191 | 30 | 4 | 9c0ee270209b02043393416ecc9a81ddedfbb8b6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.08e-06 | 192 | 30 | 4 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.24e-06 | 193 | 30 | 4 | 8b77625bf3c87d39767fb391d1beaca4ab02342b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.24e-06 | 193 | 30 | 4 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.24e-06 | 193 | 30 | 4 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW12-Neuronal-GABAergic_neurons|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 8.58e-06 | 195 | 30 | 4 | efdea22118d5be46c5abfe8e3fbe39503390665d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.94e-06 | 197 | 30 | 4 | 2430f31d9312338e0ca23bfc6bdb0365340860fd | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.12e-06 | 198 | 30 | 4 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.30e-06 | 199 | 30 | 4 | ba284f984909504221900bca5ea12ada5b2ffd9f | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.49e-06 | 200 | 30 | 4 | 858421b91f5207b7934b5c219752cb9322a3da31 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.49e-06 | 200 | 30 | 4 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.49e-06 | 200 | 30 | 4 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.49e-06 | 200 | 30 | 4 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.49e-06 | 200 | 30 | 4 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.49e-06 | 200 | 30 | 4 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.49e-06 | 200 | 30 | 4 | a7022762c1d8aedb7b3e9605873b1e68b9907b35 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.49e-06 | 200 | 30 | 4 | 2131c8e7fa054b79906eaf60536da892438b09cd | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.49e-06 | 200 | 30 | 4 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.02e-05 | 99 | 30 | 3 | c8fcfc92bcb0c19dc4aaf4e67d263b936d41d589 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.14e-05 | 100 | 30 | 3 | 32219094edb6e3c81222d5fcfbf222b7fdc58fa3 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Oprk1_(Claustrum_cortex)|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.63e-05 | 128 | 30 | 3 | 7e3f5cea91af005f08d8e9340fb8630bf1c887c3 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.63e-05 | 128 | 30 | 3 | a876303c852db2af9418d1a1711d7c950805018a | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Oprk1_(Claustrum_cortex)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.63e-05 | 128 | 30 | 3 | 388062f840fd04cb8087f27a9a78e7a192920e3e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.89e-05 | 134 | 30 | 3 | e0f3ca643c206929203d80095663a5eac98ac088 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.22e-04 | 144 | 30 | 3 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Mucinous_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.25e-04 | 145 | 30 | 3 | 1e52e3c615b49e7388cd58a04e74cafac9552447 | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.33e-04 | 148 | 30 | 3 | 5983c4546f527a0b599cfcbd8a6cb937a1d6f895 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.33e-04 | 148 | 30 | 3 | 5e738522d4ad35e08bc4ff8c41b7bea38ec6ef95 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Mucinous_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.35e-04 | 149 | 30 | 3 | 649eb3441fa859591ea85f1ed5fcf08af272a32b | |
| ToppCell | Substantia_nigra-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.38e-04 | 150 | 30 | 3 | edbc1d29d213bf5908592135700e0d80e123c923 | |
| ToppCell | Substantia_nigra-Hematopoietic-MICROGLIA|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.38e-04 | 150 | 30 | 3 | d44c02402e59a45e40b8fffbe71284032b5e7c92 | |
| ToppCell | Substantia_nigra-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.38e-04 | 150 | 30 | 3 | 01c526e1e3007e71e416c317549fddd2919b14e9 | |
| ToppCell | Substantia_nigra-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.38e-04 | 150 | 30 | 3 | b7f5bf9af7ed50aad4da1c71d37b8b9709e6ce85 | |
| ToppCell | Substantia_nigra-Hematopoietic-MICROGLIA-MI2(C1qb)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.38e-04 | 150 | 30 | 3 | e020dbcf85c0ba7ad667b8bbeb6bbcfc135c9bb7 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.58e-04 | 157 | 30 | 3 | 741d79c10cb87fa7f14080c6fccb1553c3a20bad | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.58e-04 | 157 | 30 | 3 | 516903469756c5fabfdf56d7bd59b3bdd7b44e39 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 160 | 30 | 3 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 160 | 30 | 3 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-04 | 162 | 30 | 3 | d28b2ea1d2c8f3c6a107991573471b6d0c49c4ae | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-04 | 162 | 30 | 3 | eed223e61c8162a2fe004ab4e09de5e037be7553 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-04 | 162 | 30 | 3 | 5bbd7130d4dad9035e73a439dda568195c136f31 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-04 | 162 | 30 | 3 | e35ddce830e20ebeac1a2c405293fc4a5323dd4a | |
| ToppCell | Basal_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.76e-04 | 163 | 30 | 3 | 679e25e5548d157d49a73057a3b5617dccda260f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_CYP26B1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.80e-04 | 164 | 30 | 3 | 902cfdb8155bb2773aa69826d5b3b810a39c8d34 | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 1.83e-04 | 165 | 30 | 3 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | Basal_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.86e-04 | 166 | 30 | 3 | aea2ae12e4746149ebc6da063ef694381c098f80 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.89e-04 | 167 | 30 | 3 | 49b19159c62d33d65ed1e59a148c11ae902fd41c | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.96e-04 | 169 | 30 | 3 | d9c3b22f62b882b8a2ea6fd9cf7afbe6d1775745 | |
| ToppCell | Immune_cells-Dendritic_cells|World / Lineage and Cell class | 2.00e-04 | 170 | 30 | 3 | 094dc211d80c89ecb1010855f1fe6eeb71bf0e20 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_RSAD2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.00e-04 | 170 | 30 | 3 | 63dfbc4746717132dc81b6bac868c7498fc96283 | |
| ToppCell | TCGA-Brain|World / Sample_Type by Project: Shred V9 | 2.00e-04 | 170 | 30 | 3 | f78e360a6a44d599ec0d207cba4704e50aa314f8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.00e-04 | 170 | 30 | 3 | 8ab67e2b6e30fdf9e9a2c02e31d4df34e751a3ed | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 2.03e-04 | 171 | 30 | 3 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.03e-04 | 171 | 30 | 3 | 79c991344f541974de4974f87a2e5372b0a55c44 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.07e-04 | 172 | 30 | 3 | e9095c3dac66cf93d31f5f88364b565abacb1e2d | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 2.10e-04 | 173 | 30 | 3 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 2.17e-04 | 175 | 30 | 3 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 2.17e-04 | 175 | 30 | 3 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 175 | 30 | 3 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | Adult-Immune-enucleated_erythrocyte-D231|Adult / Lineage, Cell type, age group and donor | 2.25e-04 | 177 | 30 | 3 | 15ee303fb6caea1fd645c3b777666196ce500a1c | |
| ToppCell | wk_15-18-Epithelial-PNS-COL20A1+_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.25e-04 | 177 | 30 | 3 | b8cc6a7abf83a9844a5293b6cc4b19135b51fd53 | |
| ToppCell | ILEUM-inflamed-(9)_Enteric_neurons|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.29e-04 | 178 | 30 | 3 | d9142151819afb0dc22bfb32a9c9dba5f553067d | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.29e-04 | 178 | 30 | 3 | 38ffbd01230c99f52274424ee6c172381daffc73 | |
| ToppCell | ILEUM-inflamed-(9)_Neuro_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.29e-04 | 178 | 30 | 3 | 611504b0a9e6318b18fba83787b03f9245c82252 | |
| ToppCell | Somatosensory_Cortex_(S1)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.32e-04 | 179 | 30 | 3 | 82348bf56a4525b2f485696cab5b2ea6e96c2f91 | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | 2.36e-04 | 180 | 30 | 3 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.40e-04 | 181 | 30 | 3 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.44e-04 | 182 | 30 | 3 | 21dcab170ffeef89faa9fee5008568cb6e15c694 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.44e-04 | 182 | 30 | 3 | f7f9be9c7ef8da9864d6aefe20043b26e1bb8697 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.44e-04 | 182 | 30 | 3 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | wk_15-18-Epithelial-PNS-SST+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.44e-04 | 182 | 30 | 3 | a7e77aaaddabf78c7784f72b3431703fc5ee4a8c | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.48e-04 | 183 | 30 | 3 | f517215ff45dec914af52dfdbc4579c19654c3aa | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.48e-04 | 183 | 30 | 3 | e0854864d377e158a4793088d1cb6b3dbf2c805d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.52e-04 | 184 | 30 | 3 | 7f6c8912677764d438ab0555faca344d74c2f483 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.56e-04 | 185 | 30 | 3 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.56e-04 | 185 | 30 | 3 | 56c7a0dbf141728ac76b8c90af197719942ca67c | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-04 | 185 | 30 | 3 | e0172e0ab0f1d7151a3c3c63bb7c84d6bda92035 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.56e-04 | 185 | 30 | 3 | a8946379fc066903fe8f4bc9cbf693b7b424a0cd | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.60e-04 | 186 | 30 | 3 | 3113c85d0ac5fc46532c19b1bb71f34b985e1276 | |
| ToppCell | PCW_07-8.5-Neuronal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.60e-04 | 186 | 30 | 3 | 7a4bb42f3f6a27b463e48eafc587d9ab3386f2fb | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.64e-04 | 187 | 30 | 3 | dfc2b95d70daf533bc0cc4ce78af9f65dd75a25b | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_B-GC_B_(I)|GI_small-bowel / Manually curated celltypes from each tissue | 2.64e-04 | 187 | 30 | 3 | a92cade2a835f5fce8de1e14650af8cdd818c296 | |
| ToppCell | PCW_05-06-Neuronal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.64e-04 | 187 | 30 | 3 | 03a2ed85b171c887d4f3b0f4fe2e1cb4a853e658 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.64e-04 | 187 | 30 | 3 | a6a112689d1c9049f57935ad9d2f4955538427de | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 188 | 30 | 3 | a244fcd092d5bd544e503366b1439b0fbc1ee00e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 188 | 30 | 3 | c8530c9ff98666c64a94683261af4288cb790a7e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.72e-04 | 189 | 30 | 3 | 06c44746fa4f02e6e2b3b635cdf2d8dfef3754d3 | |
| ToppCell | wk_08-11-Epithelial-PNS-Schwann_precursor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.77e-04 | 190 | 30 | 3 | 4a777d8aa19cadd3b61b023772df142421a89113 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.81e-04 | 191 | 30 | 3 | de54dab85db70f847de75b3b6d7667a0e13b9bfb | |
| ToppCell | Basal_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.81e-04 | 191 | 30 | 3 | a98915bad9a4a61dd4cbca798914849b805f4a19 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.81e-04 | 191 | 30 | 3 | 0f9443da0f73d07456142fae08b2dc92a5b7b592 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.81e-04 | 191 | 30 | 3 | a53616c84178eb6c29b48662358765b082df3f97 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.90e-04 | 193 | 30 | 3 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.90e-04 | 193 | 30 | 3 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| Computational | Ion channels. | 2.13e-06 | 70 | 15 | 4 | MODULE_316 | |
| Drug | decahydroisoquinoline | 2.44e-14 | 16 | 30 | 6 | CID000097812 | |
| Drug | LY382884 | 8.24e-14 | 19 | 30 | 6 | CID000656723 | |
| Drug | AC1L1B62 | 1.64e-13 | 21 | 30 | 6 | CID000001299 | |
| Drug | NS 102 | 2.26e-13 | 22 | 30 | 6 | CID005282252 | |
| Drug | Ly294486 | 3.51e-13 | 9 | 30 | 5 | CID005311255 | |
| Drug | 1m5b | 3.51e-13 | 9 | 30 | 5 | CID000447081 | |
| Drug | LY339434 | 3.51e-13 | 9 | 30 | 5 | CID006324635 | |
| Drug | Benzoates | 7.01e-13 | 10 | 30 | 5 | ctd:D001565 | |
| Drug | sym 2206 | 1.28e-12 | 11 | 30 | 5 | CID005039877 | |
| Drug | LY293558 | 1.78e-12 | 30 | 30 | 6 | CID000127894 | |
| Drug | Atpa | 2.20e-12 | 12 | 30 | 5 | CID000002252 | |
| Drug | 4-methylglutamic acid | 2.21e-12 | 31 | 30 | 6 | CID000005365 | |
| Drug | willardine | 2.72e-12 | 32 | 30 | 6 | CID000005123 | |
| Drug | L-BMAA | 8.24e-12 | 38 | 30 | 6 | CID000028558 | |
| Drug | DETC-MeSO | 9.73e-12 | 39 | 30 | 6 | CID003035711 | |
| Drug | Joro spider toxin | 1.81e-11 | 43 | 30 | 6 | CID000119582 | |
| Drug | philanthotoxin | 2.41e-11 | 45 | 30 | 6 | CID000115201 | |
| Drug | IDRA 21 | 4.28e-11 | 20 | 30 | 5 | CID000003688 | |
| Drug | AC1L1FA8 | 4.69e-11 | 50 | 30 | 6 | CID000003150 | |
| Drug | LY354740 | 5.31e-11 | 51 | 30 | 6 | CID000114827 | |
| Drug | AC1L1EKQ | 6.00e-11 | 52 | 30 | 6 | CID000002834 | |
| Drug | CX516 | 7.25e-11 | 22 | 30 | 5 | CID000148184 | |
| Drug | thio-ATPA | 8.55e-11 | 7 | 30 | 4 | CID005289517 | |
| Drug | GYKI 52466 | 1.19e-10 | 58 | 30 | 6 | CID000003538 | |
| Drug | Ns102 | 1.46e-10 | 25 | 30 | 5 | CID005311098 | |
| Drug | homoibotenic acid | 1.71e-10 | 8 | 30 | 4 | CID000194385 | |
| Drug | L-Glutamic Acid | 3.18e-10 | 68 | 30 | 6 | DB00142 | |
| Drug | AC1NUW3V | 3.25e-10 | 29 | 30 | 5 | CID005462126 | |
| Drug | felbamate | 3.80e-10 | 70 | 30 | 6 | CID000003331 | |
| Drug | AC1L1E5T | 5.35e-10 | 74 | 30 | 6 | CID000002653 | |
| Drug | AC1L1DME | 5.81e-10 | 75 | 30 | 6 | CID000002414 | |
| Drug | 6,7-dinitroquinoxaline | 6.47e-10 | 33 | 30 | 5 | CID002724608 | |
| Drug | J-ST | 8.03e-10 | 11 | 30 | 4 | CID005288655 | |
| Drug | YM872 | 8.03e-10 | 11 | 30 | 4 | CID000148200 | |
| Drug | kainite | 8.83e-10 | 35 | 30 | 5 | CID000164810 | |
| Drug | R,S)-AMPA | 1.02e-09 | 36 | 30 | 5 | CID000001221 | |
| Drug | D-N-Q | 1.16e-09 | 84 | 30 | 6 | CID000003140 | |
| Drug | gamma-Glu-Gly | 1.18e-09 | 37 | 30 | 5 | CID000100099 | |
| Drug | C-X6 | 1.20e-09 | 12 | 30 | 4 | CID005288002 | |
| Drug | GAMs | 1.36e-09 | 38 | 30 | 5 | CID000002935 | |
| Drug | CGS 19755 | 1.36e-09 | 38 | 30 | 5 | CID000068736 | |
| Drug | HA-966 | 1.56e-09 | 39 | 30 | 5 | CID000001232 | |
| Drug | Naspm | 1.74e-09 | 13 | 30 | 4 | CID000129695 | |
| Drug | hexachlorophene | 1.77e-09 | 90 | 30 | 6 | CID000003598 | |
| Drug | aurintricarboxylic acid | 1.90e-09 | 91 | 30 | 6 | CID000002259 | |
| Drug | 1xa5 | 2.16e-09 | 93 | 30 | 6 | CID000157684 | |
| Drug | quinoxaline-2,3-dione | 2.43e-09 | 14 | 30 | 4 | CID011469229 | |
| Drug | LY341495 | 2.60e-09 | 43 | 30 | 5 | CID006324636 | |
| Drug | LY 300164 | 2.60e-09 | 43 | 30 | 5 | CID000126756 | |
| Drug | 7-chlorokynurenic acid | 3.29e-09 | 45 | 30 | 5 | CID000001884 | |
| Drug | thiokynurenic acid | 3.31e-09 | 15 | 30 | 4 | CID003035667 | |
| Drug | cyclothiazide | 4.02e-09 | 103 | 30 | 6 | CID000002910 | |
| Drug | ODAP | 4.60e-09 | 48 | 30 | 5 | CID000002360 | |
| Drug | methylenecyclopropylglycine | 5.12e-09 | 49 | 30 | 5 | CID000441452 | |
| Drug | 7-Cl-Thio-Kyna | 5.76e-09 | 17 | 30 | 4 | CID003035668 | |
| Drug | Quinoxaline | 6.96e-09 | 52 | 30 | 5 | CID000007045 | |
| Drug | MNQX | 7.40e-09 | 18 | 30 | 4 | CID000130818 | |
| Drug | 3-pyridazinol 1-oxide | 8.25e-09 | 4 | 30 | 3 | CID000574311 | |
| Drug | isoxazole | 1.02e-08 | 56 | 30 | 5 | CID000009254 | |
| Drug | kynurenic acid | 1.12e-08 | 122 | 30 | 6 | CID000003845 | |
| Drug | Nf023 | 1.17e-08 | 20 | 30 | 4 | CID005311313 | |
| Drug | 3,7-diaminoheptan-2-one | 1.58e-08 | 61 | 30 | 5 | CID004477684 | |
| Drug | pyrrolidine-2,4-dicarboxylate | 1.58e-08 | 61 | 30 | 5 | CID000003868 | |
| Drug | aniracetam | 1.64e-08 | 130 | 30 | 6 | CID000002196 | |
| Drug | AC1L1YEG | 2.06e-08 | 5 | 30 | 3 | CID000063114 | |
| Drug | Chicago acid | 2.06e-08 | 5 | 30 | 3 | CID000065740 | |
| Drug | irampanel | 2.06e-08 | 5 | 30 | 3 | CID003038472 | |
| Drug | CHEBI:570577 | 2.06e-08 | 5 | 30 | 3 | CID011334126 | |
| Drug | beta-N-oxalylaminoalanine | 2.06e-08 | 5 | 30 | 3 | CID000107978 | |
| Drug | LY395153 | 2.06e-08 | 5 | 30 | 3 | CID000656707 | |
| Drug | 5-h PCA | 2.06e-08 | 5 | 30 | 3 | CID000129091 | |
| Drug | 1-BCP | 2.06e-08 | 5 | 30 | 3 | CID000001370 | |
| Drug | CGP 39653 | 2.55e-08 | 24 | 30 | 4 | CID006437837 | |
| Drug | pD 8 | 2.55e-08 | 24 | 30 | 4 | CID000656948 | |
| Drug | DE gel | 2.90e-08 | 143 | 30 | 6 | CID000008146 | |
| Drug | pseudococaine | 3.25e-08 | 570 | 30 | 9 | CID000002826 | |
| Drug | ifenprodil | 3.43e-08 | 71 | 30 | 5 | CID000003689 | |
| Drug | AC1Q3ZOL | 3.60e-08 | 258 | 30 | 7 | CID000002376 | |
| Drug | AC1L9FMM | 3.95e-08 | 73 | 30 | 5 | CID000444055 | |
| Drug | 2cmo | 4.12e-08 | 6 | 30 | 3 | CID006914597 | |
| Drug | YM928 | 4.12e-08 | 6 | 30 | 3 | CID006918393 | |
| Drug | 2-amino-3-phosphonopropionic acid | 4.84e-08 | 76 | 30 | 5 | CID000003857 | |
| Drug | AC1L32TU | 6.55e-08 | 30 | 30 | 4 | CID000107831 | |
| Drug | cis-2,3-piperidine dicarboxylic acid | 6.55e-08 | 30 | 30 | 4 | CID000001226 | |
| Drug | QX-314 | 7.11e-08 | 82 | 30 | 5 | CID000003925 | |
| Drug | 4,6-dichloroindole-2-carboxylic acid | 7.20e-08 | 7 | 30 | 3 | CID000127988 | |
| Drug | AC1L1B1W | 8.03e-08 | 84 | 30 | 5 | CID000001248 | |
| Drug | alpha-methyl-4-carboxyphenylglycine | 8.58e-08 | 32 | 30 | 4 | CID000001222 | |
| Drug | riluzole | 9.32e-08 | 174 | 30 | 6 | CID000005070 | |
| Drug | D-CPPene | 1.10e-07 | 34 | 30 | 4 | CID006435801 | |
| Drug | L-quisqualic acid | 1.14e-07 | 180 | 30 | 6 | CID000001209 | |
| Drug | 2,3-PDCA | 1.15e-07 | 8 | 30 | 3 | CID000127037 | |
| Drug | 1-hydroxyimidazole | 1.15e-07 | 8 | 30 | 3 | CID003614351 | |
| Drug | BTDS | 1.15e-07 | 8 | 30 | 3 | CID003034022 | |
| Drug | 1-hydroxypyrazole | 1.15e-07 | 8 | 30 | 3 | CID003016733 | |
| Drug | 2-amino-4-phosphonobutyric acid | 1.20e-07 | 91 | 30 | 5 | CID000002207 | |
| Drug | gamma-aminobutyric acid | 1.30e-07 | 474 | 30 | 8 | CID000000119 | |
| Drug | PhTX-343 | 1.40e-07 | 36 | 30 | 4 | CID000159548 | |
| Drug | C6H12NO5P | 1.40e-07 | 36 | 30 | 4 | CID000104962 | |
| Drug | isothiazol-3-one | 1.72e-07 | 9 | 30 | 3 | CID000096917 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 8.53e-11 | 145 | 29 | 7 | DOID:1289 (implicated_via_orthology) | |
| Disease | Frigidity | 1.70e-08 | 6 | 29 | 3 | C0016722 | |
| Disease | Psychosexual Disorders | 1.70e-08 | 6 | 29 | 3 | C0033953 | |
| Disease | Hypoactive Sexual Desire Disorder | 1.70e-08 | 6 | 29 | 3 | C0020594 | |
| Disease | Sexual Arousal Disorder | 1.70e-08 | 6 | 29 | 3 | C0036902 | |
| Disease | Orgasmic Disorder | 1.70e-08 | 6 | 29 | 3 | C0029261 | |
| Disease | Schizophrenia | 1.08e-07 | 883 | 29 | 9 | C0036341 | |
| Disease | central nervous system disease (implicated_via_orthology) | 4.74e-07 | 16 | 29 | 3 | DOID:331 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | 5.99e-06 | 477 | 29 | 6 | C0005586 | |
| Disease | Mental Depression | 1.08e-04 | 254 | 29 | 4 | C0011570 | |
| Disease | Depressive disorder | 1.76e-04 | 289 | 29 | 4 | C0011581 | |
| Disease | Developmental Academic Disorder | 3.72e-04 | 29 | 29 | 2 | C1330966 | |
| Disease | Learning Disorders | 3.72e-04 | 29 | 29 | 2 | C0023186 | |
| Disease | Learning Disturbance | 3.72e-04 | 29 | 29 | 2 | C0751263 | |
| Disease | Adult Learning Disorders | 3.72e-04 | 29 | 29 | 2 | C0751262 | |
| Disease | Learning Disabilities | 3.72e-04 | 29 | 29 | 2 | C0751265 | |
| Disease | unipolar depression, bipolar disorder | 4.79e-04 | 156 | 29 | 3 | EFO_0003761, MONDO_0004985 | |
| Disease | Malignant neoplasm of breast | 5.31e-04 | 1074 | 29 | 6 | C0006142 | |
| Disease | lysophosphatidylcholine 20:3 measurement | 7.11e-04 | 40 | 29 | 2 | EFO_0010362 | |
| Disease | Autistic Disorder | 2.11e-03 | 261 | 29 | 3 | C0004352 | |
| Disease | Malignant Glioma | 2.16e-03 | 70 | 29 | 2 | C0555198 | |
| Disease | mixed gliomas | 2.16e-03 | 70 | 29 | 2 | C0259783 | |
| Disease | Depression, Bipolar | 2.74e-03 | 79 | 29 | 2 | C0005587 | |
| Disease | Glioma | 3.31e-03 | 87 | 29 | 2 | C0017638 | |
| Disease | Psychotic Disorders | 4.43e-03 | 101 | 29 | 2 | C0033975 | |
| Disease | non-high density lipoprotein cholesterol measurement | 4.97e-03 | 713 | 29 | 4 | EFO_0005689 | |
| Disease | stroke outcome severity measurement | 5.61e-03 | 114 | 29 | 2 | EFO_0009603 | |
| Disease | Drug Use Disorders | 5.71e-03 | 115 | 29 | 2 | C0013222 | |
| Disease | Drug Dependence | 5.71e-03 | 115 | 29 | 2 | C1510472 | |
| Disease | Drug habituation | 5.71e-03 | 115 | 29 | 2 | C0013170 | |
| Disease | Substance Dependence | 5.71e-03 | 115 | 29 | 2 | C0038580 | |
| Disease | Substance Use Disorders | 5.71e-03 | 115 | 29 | 2 | C0038586 | |
| Disease | Substance-Related Disorders | 5.71e-03 | 115 | 29 | 2 | C0236969 | |
| Disease | Drug abuse | 5.71e-03 | 115 | 29 | 2 | C0013146 | |
| Disease | Organic Mental Disorders, Substance-Induced | 5.71e-03 | 115 | 29 | 2 | C0029231 | |
| Disease | Prescription Drug Abuse | 5.71e-03 | 115 | 29 | 2 | C4316881 | |
| Disease | Substance abuse problem | 5.80e-03 | 116 | 29 | 2 | C0740858 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KSKISTYEKMWAFMS | 711 | P39086 | |
| PMAVFFDYSKESFWK | 1266 | Q6DHV5 | |
| LMMWDFKKYYVSNFS | 476 | Q9H714 | |
| FKMKWQYTNRRAFTM | 151 | Q96P65 | |
| KYGMPSSHSQFMWFF | 96 | Q86YN1 | |
| KMWSYMKSAEPSVFT | 701 | P42263 | |
| KMWTYMRSAEPSVFT | 691 | P48058 | |
| IMIKFWTAMFSDKKY | 1406 | P42356 | |
| AMKMVAPWTRFYSNS | 91 | Q86VI4 | |
| DKMDSRTFTNVYWMK | 226 | Q9HBH1 | |
| YSCDMKSSFSKYWKP | 301 | Q9NPB8 | |
| MAALTDLSFMYRWFK | 1 | Q8NEX9 | |
| SWRFYSRHKTMNFMS | 6456 | Q8NDH2 | |
| SKIAVFEKMWTYMKS | 676 | P42261 | |
| FEKMWTYMKSAEPSV | 681 | P42261 | |
| KSKISTYDKMWAFMS | 696 | Q13002 | |
| ISTFEKMWAFMSSKP | 701 | Q13003 | |
| EWSAPDTMKRYSMYL | 461 | Q14134 | |
| SRFMYPKEWQHLTMF | 61 | Q5T9Z0 | |
| VGALSKSMYERMFKW | 436 | Q9Y2K3 | |
| MTKYSQESWFKMPKF | 5181 | Q8IVF2 | |
| MEKFKTPWRKFFTSM | 296 | Q9P2U8 | |
| QPTMKFVMDTSKYWF | 436 | Q8IZW8 | |
| KWLTKSFHFPLFMTM | 36 | Q9NQQ7 | |
| MMFSSKYWARRGFSL | 6 | Q8IWU9 | |
| TASREYKKMFKQTWM | 181 | P11388 | |
| KTSFMMLFEWIYPSY | 736 | Q9UIA9 | |
| KTEKLMFSTYFMDLW | 2766 | Q70CQ2 | |
| DFPASFRKSTYWMKM | 66 | Q96ME7 | |
| MKMFDRWTYSISKNT | 91 | O75795 | |
| FFAAMFYMLKGSWEA | 486 | Q86W24 |